All stories tagged :

Pr Newswire

Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer

admin
Pr Newswire

UPL RECOGNIZED AS LEADING AGROCHEMICAL COMPANY IN DOW JONES SUSTAINABILITY INDICES...

admin
Pr Newswire

NGM Bio and KdT Ventures Enter into Worldwide License Agreement for...

admin
Pr Newswire

Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting...

admin
Pr Newswire

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of...

admin
Pr Newswire

NMD Pharma Announces Publication of Phase 1 Clinical Trial Data Evaluating...

admin
Pr Newswire

Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for...

admin
Pr Newswire

/C O R R E C T I O N —...

admin
Pr Newswire

China Daily’s special coverage celebrates Macao’s return to the motherland

admin
Pr Newswire

X Financial Announces US$48.7 Million Share Repurchase from Major Shareholder

admin
Pr Newswire

Anticimex Sweden upgrades to IFS Cloud to boost efficiency across its...

admin

Featured

Pr Newswire

Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results...

admin
Pr Newswire

JenaValve’s Trilogy™ THV System Procedures Live Broadcast at New York Valves...

admin
People

REsimpli Launches Game-Changing AI-Powered CRM Tools for Real Estate Investors

admin
People

The World’s Most Prestigious Street Pole Vault Competition Comes to Asia!

admin
admin

Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results...

MINNEAPOLIS, July 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2025 after the close of trading on Monday, August 4. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time...